What is being studied
Tirzepatide activates GIP and GLP-1 receptors. Research explores metabolic regulation, glucose control and body-weight outcomes.
RESEARCH PEPTIDE
Tirzepatide 30 mg
In preparationExplore the listed product information and available batch documentation.
- Product name
- Tirzepatide
- Listed quantity
- 30 mg
- Intended use
- Laboratory research only
- Specifications
- Not yet published
- Availability
- Not available for purchase yet
- Certificate of analysis
- Not yet published
Research reference
Incretin biology & metabolic research
A summary of selected literature about the substance. These are not trials of the EVALON product or instructions for use.
Published evidence
Randomized phase 3 trials studied clinical formulations in adults with obesity, with and without type 2 diabetes. They evaluated outcomes and adverse events.
Limits of the evidence
Evidence for a clinical formulation does not establish equivalence or suitability for human use of this research product.